Publication | Open Access
The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients
184
Citations
33
References
2012
Year
This study demonstrates clinical utility for the use of baseline IRG expression levels as a predictive biomarker for non-response to RTX in RA.
| Year | Citations | |
|---|---|---|
Page 1
Page 1